Clinical trial
The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With Rotational Thromboelastometry (ROTEM)
NCT05669313 is registered in ClinicalTrials.gov with Thomas Kander as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With Rotational Thromboelastometry (ROTEM)
- Lead sponsor
- Thomas Kander
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 4, 2022
- Completion date
- November 10, 2022
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acidosis, bleeding, hypothermia, trauma